Skip to main content
SpringerLink
Log in

Importance of Long-Term Follow-up in Evaluating Treatment Regimens for Adults with Acute Lymphoblastic Leukemia

  • Conference paper
Acute Leukemias II

Part of the book series: Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ((HAEMATOLOGY,volume 33))

Abstract

A complete report was recently published [1] which describes the results of our experience at Memorial Hospital in the treatment of adults with acute lymphoblastic leukemia during the past 20 years as of December 1986 and compares them with those of other large published series. In this paper I will update our overall experience, summarize the results of our most recent trials, and discuss our future plans.

The results reported here were previously presented at The UCLA Symposia on Molecular and Cellular Biology entitled: “Acute Lymphoblastic Leukemia: Current Controversies, Future Directions,” held at Tapatio Springs, Texas, United States, 29 November–2 December 1988; and will be published in the UCLA Symposia on Molecular and Cellular Biology, New Series, Volume 108:Acute Lymphoblastic Leukemia. Edited by: Gale RP, Hoelzer D, Alan R. Liss, New York (in press, 1989)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Gaynor J, Chapman D, Little C, McKenzie S, Miller W, Andreeff M, Arlin Z, Berman E, Kempin S, Gee T, Clarkson B (1988) A causespecific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. J Clin Oncol 6: 1014–1030

    PubMed  CAS  Google Scholar 

  2. Clarkson BD, Fried J (1971) Changing concepts of treatment in acute leukemia. Med Clin North Am 55: 561–600

    PubMed  CAS  Google Scholar 

  3. Gee TS, Dowling MD, Haghbin M, Clarkson B (1976) Acute lymphocytic leukemia in adults and children. Differences in responses on a single therapeutic regimen. Cancer 37: 1256–1264

    Article  PubMed  CAS  Google Scholar 

  4. Schauer P, Arlin ZA, Mertelsmann R, Cirrincione C, Friedman A, Gee TS, Dowling M, Kempin S, Straus DJ, Koziner B, McKenzie S, Thaler HZ, Dufour P, Little C, Dellaquila C, Ellis S, Clarkson B (1983) Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols. J Clin Oncol 1: 462–470

    PubMed  CAS  Google Scholar 

  5. Clarkson B, Ellis S, Little C, Gee T, Arlin Z, Mertelsmann R, Andreeff M, Kempin S, Koziner B, Chaganti R, Jhanwar S, McKenzie S, Cirrincione C, Gaynor J (1985) Acute lymphoblastic leukemia in adults. Semin Oncol 12: 160–179

    PubMed  CAS  Google Scholar 

  6. Clarkson BD (1974) The survival value of the dormant state in neoplastic and normal cell populations. In: Clarkson B, Baserga R (eds) Control of proliferation in animal cells. Cold Spring Harbor Laboratory, New York, pp 945–972

    Google Scholar 

  7. Clarkson B (1975) Consideration of cell kinetic principles to strategy of treating leukemia. In: Cancer chemotherapy–fundamental concepts and recent advances. Year Book Medical, New York, pp 19–50

    Google Scholar 

  8. Clarkson BD, Fried J, Chou T-C, Strife A, Ferguson R, Sullivan S, Kitahara T, Oyama A (1977) Duration of the dormant state in an established cell line of human hematopoietic cells. Cancer Res 37: 4506–4522

    PubMed  CAS  Google Scholar 

  9. Haghbin M, Tan CTC, Clarkson BD, Mike V, Burchenal JH, Murphy ML (1975) Treatment of acute lymphoblastic leukemia in children with “prophylactic” intrathecal methotrexate and intensive systemic chemotherapy. Cancer Res 35: 807–811

    PubMed  CAS  Google Scholar 

  10. Clarkson BD, Haghbin M, Murphy ML, Gee TS, Dowling MD, Arlin ZA, Kempin S, Posner J, Shapiro W, Galicich J, Du Four P, Passe S, Burchenal JH (1979) Prevention of central nervous system leukaemia in acute lymphoblastic leukaemia with prophylactic chemotherapy alone. In: Whitehouse JMA, Kay HEM (eds) CNS complications of malignant disease. Macmillan, London, pp 36 - 58

    Google Scholar 

  11. Gulati SC, Shank B, Black P, Yopp J, Koziner B, Straus D, Filippa D, Kempin S, Castro-Malaspina H, Cunningham I, Berman E, Coleman M, Langleben A, Colvin OM, Fuks Z, O’Reilly R, Clarkson B (1988) Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. J Clin Oncol 6: 1303 - 1313

    PubMed  CAS  Google Scholar 

  12. Steinherz PG, Gaynon P, Miller DR et al. (1986) Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen - a new intensive therapy protocol. A report from the Children’s Cancer Study Group. J Clin Oncol 4: 744

    PubMed  CAS  Google Scholar 

  13. Meloni G, Amadori S, Carella AM et al. (1987). High-dose cytarabine and idarubicin for the treatment of advanced acute lymphoblastic leukemia. In: 4th International symposium on therapy of acute leukemia, 18. Excerpta Medica, Amsterdam, p 18

    Google Scholar 

  14. Hoelzer D, Thiel E, Loffler H, Buchner T, Ganser A, Heil G, Koch P, Freund M, Diedrich H, Ruhl H, Maschmeyer G, Lipp T, Nowrousian MR, Burkert M, Gerecke D, Pralle H, Muller U, Lunscken C, Fülle H, Ho AD, Kuchler R, Busch FW, Schneider W, Gorg CH, Emmerich B, Braumann D, Vaupel HA, von Paleske A, Bartels H, Neiss A, Messerer D (1988) Prognostic factors in a multi-center study for treatment of acute lymphoblastic leukemia in adults. Blood 71: 123–131

    PubMed  CAS  Google Scholar 

  15. Willemze R, Peters WG, Colly LP (1988) Short-term intensive treatment ( V.A.A.P.) of adult acute lymphoblastic leukemia andlymphoblastic lymphoma. Eur J Haematol 41: 489–495

    Article  PubMed  CAS  Google Scholar 

  16. Baccarani M, Corbelli G, Amadori S et al. (1982) Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. Blood 60: 677–684

    PubMed  CAS  Google Scholar 

  17. Marcus RE, Catovsky D, Johnson SA, Gregory WM, Talavera JG, Goldman JM, Galton DAG (1986) Adult acute lymphoblastic leukemia: a study of prognostic features and response to treatment over a ten year period. Br J Cancer 53: 175

    Article  PubMed  CAS  Google Scholar 

  18. Linker CA, Levitt LJ, O’Donnell M, Ries CA, Forman SJ (1987) Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia. Semin Oncol 14: 78–85

    PubMed  CAS  Google Scholar 

  19. Hussein KK, Dahlberg S, Head D, Waddell CC, Dabich L, Weick JK, Morrison F, Saiki JH, Metz E, Rivkin SE, Grever MR, Boldt D and the Southwest Oncology Group (1989) Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy. Blood 73: 57–63

    PubMed  CAS  Google Scholar 

  20. Radford JE, Burns CP, Jones MP, Gingrich RD, Kemp JD, Edwards RW, McFadden DB, Dick FR, Wen BC (1989) Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol. J Clin Oncol 7: 58–66

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Memorial Sloan-Kettering Cancer Center New York, New York, 10021, USA

    B. Clarkson, J. Gaynor, C. Little, E. Berman, S. Kempin, M. Andreeff, S. Gulati, I. Cunningham & T. Gee

Authors
  1. B. Clarkson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Gaynor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Little
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Berman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Kempin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Andreeff
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Gulati
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. I. Cunningham
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. T. Gee
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Internal Medicine and Pediatrics, University of Münster, Albert-Schweitzer-Straße 33, D-4400, Münster, Federal Republic of Germany

    T. Büchner , G. Schellong , W. Hiddemann  & J. Ritter , ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Clarkson, B. et al. (1990). Importance of Long-Term Follow-up in Evaluating Treatment Regimens for Adults with Acute Lymphoblastic Leukemia. In: Büchner, T., Schellong, G., Hiddemann, W., Ritter, J. (eds) Acute Leukemias II. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74643-7_75

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74643-7_75

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-50984-4

  • Online ISBN: 978-3-642-74643-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation